In recent years, FTH1 as a master regulator of ferroptosis has been reported as a prognostic factor in brain cancer, pancreatic cancer, kidney cancer and breast cancer (Chekhun et al., 2014; Huang et al., 2019; Rosager et al., 2017; Su, Lei & Zhang, 2017). Here, FTH1 is linked to breast carcinoma.